• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Drugs.com, TrialReach to give patients access to drugs in development

Drugs.com, TrialReach to give patients access to drugs in development

February 13, 2014
CenterWatch Staff

Drugs.com, an online clinical drug resource, and TrialReachare partnering to provide patients with information and access to treatments that are still under development. The new partnership will bring TrialReach's patient-centric content and tools directly to the 25 million people who visit Drugs.com every month.

From a patient's perspective, clinical trials offer more treatment options when the standard ones fail. They also give patients the opportunity to participate in medical research that may also help other patients in the future.

"There are millions of patients searching for information about medicines on Drugs.com. Giving them the ability to find information about new drugs in development is a natural extension of how people are using the site today," said Pablo Graiver, TrialReach CEO. "But we want to go beyond this. Our partnership gives us the opportunity to give many more patients the ability to voice their needs and experiences so researchers can design better treatments and trials in the future."

"As the Internet's largest provider of information about medicines, it only makes sense that we would give our community information about the latest drugs in development and give them an opportunity to participate in clinical trials," says Philip Thornton, CEO of Drugs.com. We chose TrialReach to partner with because they are delivering a much better experience for patients through technology and insight."

The intersection of technology, data science and social media is creating unparalleled opportunities to gather information and insights about drug development and testing from understanding how and where trials should be conducted to how clinical trials can be made more accessible and less burdensome to patients.

"Everyone is talking about big data but we have to go beyond data to actionable insights so we can deliver something meaningful to patients," said Graiver. "What do patients care about? What are they experiencing?  We think that by allowing people to 'voice' their knowledge and their experience of clinical trials either directly on our site or through social media, we can make clinical trial information more up-to-date, more relevant and more valuable to patients and researchers than ever before."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing